LONG TERM GOAL: To characterize the receptors and underlying mechanism of action of adrenalcortical steroids on hippocampal pyramidal cell activity. Adrenalcortical receptors in the hippocampus adjust corticosterone (CT) levels by regulating the hypothalamic-pituitary-adrenal axis (HPA). Homeostasis is maintained by basal activation of the hippocampal-HPA. In response to stress, CT secretion is increased. CT activation of receptors in the hippocampus leads to feedback inhibition of the HPA. Excessive CT secretion is neurotoxic to hippocampal pyramidal cells. The mechanism of the hippocampal regulation of the HPA is unknown. A step towards understanding this mechanism is to determine how CT alters pyramidal cell excitability. The hippocampal slice preparation in vitro will be used for intracellular recordings. CT concentrations will be controlled by adrenalectomy (ADX) and steroid replacement.
SPECIFIC AIM #1 : To determine the contribution of chronic CT receptor activation to pyramidal cell excitability. HYPOTHESES: Persistent Type 1 receptor activation, the non-stressed condition, will result in pyramidal cell depolarization and increased cell excitability as compared to cells from ADX rats. Chronic Type 1 and Type 2 receptor activation, the chronically stressed state, will decrease cell excitability to prolonged synaptic input by increasing the amplitude of an evoked slow hyperpolarization (sAHP).
SPECIFIC AIM #2 : To characterize the receptors mediating changes in hippocampal pyramidal cell physiology induced by acute CT administration. HYPOTHESES: Type 1 receptor activation will increase a cationic conductance and synaptic activation. Type 2 receptor activation will reduce prolonged synaptic excitability by increasing the sAHP amplitude. Activation of a plasma membrane receptor will hyperpolarize cells. The ionic mechanisms underlying these responses and genomic mediation will be determined SPECIFIC AIM #3: To determine the effect of chronic CT treatment on responses mediated by 5-hydroxytryptamine (5-HT) receptors. 5-HT exerts profound effects on pyramidal cells, and CT modulates 5-HT synthesis and receptor number. HYPOTHESES: CT will increase the sensitivity of the 5-HT(1A) hyperpolarization and decrease the sensitivity of the 5-HT receptor that decreases the amplitude of the sAHP. These results will provide important information on the control of pyramidal cell activity by CT and will help elucidate the mechanism of hippocampal regulation of the HPA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS028512-03
Application #
3415051
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1991-01-01
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Loyola University Chicago
Department
Type
Schools of Medicine
DUNS #
791277940
City
Maywood
State
IL
Country
United States
Zip Code
60153
Kirby, L G; Pernar, L; Valentino, R J et al. (2003) Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116:669-83
Neumaier, J F; Sexton, T J; Hamblin, M W et al. (2000) Corticosteroids regulate 5-HT(1A) but not 5-HT(1B) receptor mRNA in rat hippocampus. Brain Res Mol Brain Res 82:65-73
Bacon, W L; Beck, S G (2000) 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 294:672-9
Muma, N A; Beck, S G (1999) Corticosteroids alter G protein inwardly rectifying potassium channels protein levels in hippocampal subfields. Brain Res 839:331-5
Okuhara, D Y; Beck, S G (1998) Corticosteroids influence the action potential firing pattern of hippocampal subfield CA3 pyramidal cells. Neuroendocrinology 67:58-66
Okuhara, D Y; Beck, S G (1998) Corticosteroids alter 5-hydroxytryptamine1A receptor-effector pathway in hippocampal subfield CA3 pyramidal cells. J Pharmacol Exp Ther 284:1227-33
Okuhara, D Y; Beck, S G; Muma, N A (1997) Corticosterone alters G protein alpha-subunit levels in the rat hippocampus. Brain Res 745:144-51
Birnstiel, S; Wulfert, E; Beck, S G (1997) Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 356:611-8
Beck, S G; Birnstiel, S; Choi, K C et al. (1997) Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acidB receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. J Pharmacol Exp Ther 281:115-22
Okuhara, D Y; Lee, J M; Beck, S G et al. (1996) Differential immunohistochemical labeling of Gs, G(il) and 2, and G(o) alpha-subunits in rat forebrain. Synapse 23:246-57

Showing the most recent 10 out of 21 publications